A potent new lipopeptide antibiotic, A54145E(Asn 3 Asp 9 ), was isolated from the fermentation broth of Streptomyces fradiae DA1489 engineered to delete genes encoding enzymes involved in hydroxylation of Asn 3 and methoxylation of Asp 9 . The chemical structure predicted from the genetic changes in the biosynthetic pathway was determined by analyses of chemical transformations, D, L-amino acid quantitation by enantiomer labeling, tandem LC-MS/MS and 2D NMR techniques. These studies confirmed the primary amino acid sequence of A54145E(Asn 3 Asp 9 ) predicted from the genetic engineering strategy, and also confirmed the structure and locations of three D-amino acids predicted from bioinformatic studies.
INTRODUCTION
Daptomycin is a cyclic 13-membered lipopeptide antibiotic approved for the treatment of complicated skin and skin structure infections caused by Gram-positive pathogens 1 and bloodstream infections (bacteremia/endocarditis) caused by Staphylococcus aureus, including methicillin-resistant strains. 2 However, daptomycin is not indicated for community-acquired pneumonia. 3 The reduction of daptomycin antibacterial activity by pulmonary surfactant may explain the failure of daptomycin in clinical trails for community-acquired pneumonia. 4 Many derivatives of daptomycin have been generated by combinatorial biosynthesis, [5] [6] [7] but none had sufficient potency in the presence of bovine surfactant to pursue clinically. 8 As part of our studies on generating derivatives of daptomycin by combinatorial biosynthesis, we cloned and sequenced the A54145 biosynthetic gene cluster to provide nonribosomal peptide synthetase (NRPS) genes, modules and domains to exchange with those of the daptomycin NRPSs. 9, 10 A54145 is a family of cyclic tridecapeptide antibiotics related to daptomycin and produced by Streptomyces fradiae. [11] [12] [13] [14] [15] The A54145 lipopeptides contain several nonproteinogenic amino acids, including hydroxyasparagine (hAsn 3 ), sarcosine (Sar 5 ), methoxyaspartic acid (moAsp 9 ) and 3-methylglutamic acid (3mGlu 12 ). 12 Four different cyclic peptide nuclei vary in the ring amino acid residues Glu/3mGlu at position 12 and Ile/Val at position 13. 12, 14 In addition, bioinformatic analysis predicted that A54145 factors would contain D-amino acids at position 2, 8 and 11 (D-Glu 2 , D-Lys 8 and D-Asn 11 ), based on the presence of epimerase domains in the respective NRPS modules. 9 The predicted locations of the D-amino acids coincide with the locations of the three D-amino acids in daptomycin, 16 suggesting that A54145 and daptomycin may have similar three-dimensional structures. The prominent natural variants have either n-decanoic (nC 10 ), iso-decanoic (iC 10 ) or anteiso-undecanoic (aC 11 ) acids attached to the terminal amino group of Trp 1 . 12, 14 By acyl tail modification, 13 a few A54145 analogs were semisynthesized for evaluation of in vitro antibacterial activity. 15 In addition, several A54145 analogs were prepared by chemoenzymatic synthesis with the excised A54145 NRPS thiolation-thioesterase di-domain to cyclize peptide thioester substrates. 17 Nevertheless, none of these derivatives have advanced to clinical studies.
While testing of daptomycin derivatives for antibacterial activity in the presence of bovine surfactant, we also tested some of the natural A54145 factors. A54145E (3mGlu 12 /Ile 13 ) was inhibited 32-fold by 1% surfactant, whereas A54145D (Glu 12 /Ile 13 ) was inhibited only by twofold. 8 This prompted us to develop a gene cloning and ectopic transcomplementation system in S. fradiae that could be used to generate combinatorial libraries of A54145 analogs, containing different combinations of amino acid substitutions in the tridecapeptide. 8, 18 We have extended the use of this genetic system to generate mutants blocked in different combinations of amino acid modifications to establish the functions of the lptJ, lptK and lptL genes, and to generate additional novel derivatives of A54145. 18 One of the novel compounds, CB-182,390 (1, Figure 1 ) had very good antibacterial activity against S. aureus, and was not inhibited by bovine surfactant. 18 In this study, we present the purification and structural characterization of 1, and demonstrate that it has two amino acid substitutions: Asn 3 for hAsn 3 and Asp 9 for moAsp 9 . Furthermore, the presence of D-amino acids in A54145 at positions 2, 8 and 11 was established.
RESULTS AND DISCUSSION S. fradiae DA1489 was engineered to delete lptJ, lptK and lptL genes responsible for hydroxylation of Asn 3 and methoxylation of Asp 9 . The strain produced a novel lipopeptide with the predicted mass ion at m/z 1626. 8 [M+H] + consistent with the presence of Asn 3 and Asp 9 substituted for hAsn 3 and moAsp 9. 18 DA1489 was fermented in DSF medium supplemented with 0.79% L-Ile in 125-ml shake flasks, and fermentation broth was collected after 6 days. It has been shown previously that the addition of L-Ile to the medium causes preferential incorporation of the anteiso-undecanoyl side chain and of L-Ile at position 13. 10, 14 An agar-based bioassay showed that the crude broth inhibited growth of S. aureus (data not shown). LC-MS analysis identified the target compound with a A54145-like UV spectra: l max 221, 279 and 288 nm 12 and ESI-MS data at m/z 1626.8 for the [M+H] + ion.
To generate sufficient quantities of the lipopeptide for characterization, structure elucidation and assessment of biological activities, 5 l of a fermentation broth of DA1489 was sequentially fractionated by Diaion HP-20 resin column chromatography, Sephadex LH-20 gel filtration size exclusion chromatography and reverse-phase C 8 HPLC to give compound 1 (16 mg). The purity was determined as greater than 95% by HPLC analysis as described in the Materials and methods section.
Compound 18 Analysis of the IR spectrum suggested that it contained one or more amine groups (3290 cm À1 ), carboxylic acid groups (1714 cm À1 ) and amide functionalities (1643 cm À1 ). The UV absorption at l max 221, 279 and 288 nm was consistent with the presence of conjugation systems contributed by the Trp moiety. 12 Standard amino acid analysis of 1 indicated the presence of one Ala, four Asx (Asp and/or Asn), one Gly, one Glx (Glu or Gln), one Ile, one Lys, one Thr and three unidentified amino acid residues because of the lack of amino acid standards. The results confirmed that compound 1 contains two additional Asx residues in comparison with A54145E. 12 The amino acid sequence of 1 was determined by the MS-MS data of the parent molecule and its linear hydrolysate 1a. The nomenclature for the amino acid sequence-determining fragmental ions was described elsewhere. 19, 20 The MS-MS spectrum of 1 showed distinct fragment peaks at m/z 1608. In this study, to confirm the presence of the three D-stereochemistry amino acids, Glu, Lys and Asp, were specifically selected for determination of their optical purity using an enantiomer-labeling method. 23 In this method, the measured optical purity of Asp was derived from both Asp and Asn residues, as Asn was converted to Asp during the DCl/D 2 Naturally occurring A54145 factors have acyl groups, which consist of n-decanoyl (nC 10 ), iso-decanoyl (iC 10 ) and anteiso-undecanoyl (aC 11 ). 12 The acyl substituent of 1 was determined by acidic hydrolysis of the lipopeptide followed by coupling the resultant FA with Trp to produce a corresponding FA-Trp amide. 21 The HPLC retention time (t R ) and UV spectra of the FA-Trp amides from a library of authentic FAs ( Figure 3a ) were compared with those of amide from 1 ( Figure 3b ). In addition, the identification of the acyl group was further confirmed by observing a homogeneous peak at t R 7.01 min after spiking the reaction resultant of 1 with the library mixture ( Figure 3c ). As a result, the anteiso-undecanoyl (aC 11 ) group was identified in 1, as expected from fermentation of S. fradiae DA1489 in DSF medium supplemented with L-Ile. 14, 18 Structural characterization of 1 by NMR studies was somewhat challenging because of the observation of two sets of 1 H-NMR signals in DMSO-d 6 . Initial NMR spectra of 1 were measured at 2 mM sample concentration in a mixture of 90% H 2 O and 10% D 2 O (pH 5.0 adjusted by HCl), 5 1C (data not shown) as described for daptomycin NMR studies. 24 However, it was found that the relatively broadresonance line widths and lack of sufficient amide proton dispersion resolution prevented the identification and full assignment of the amino acid spin systems. The broad resonance line widths may have resulted from the significant aggregation tendency of the lipopeptide molecule in aqueous solution. 24 DMSO-d 6 was, therefore, selected as an alternative NMR solvent. Interestingly, two sets of proton resonances at a ratio of approximately 3:2 were observed for 1 at room temperature in DMSO-d 6 . This phenomenon was observed for all A54145 analogs (unpublished data). Furthermore, a series of 1 H-NMR studies were carried out in DMSO-d 6 at various temperatures, including 25, 30, 40, 50, 60, 70 and 80 1C. These data showed partial coalescence of 1 H-NMR signals at elevated temperature, consistent with the presence of slowly exchanging conformers such as peptide amide rotamers. 25 In addition, the spectrum measured at 40 1C exhibited the optimal proton dispersion resolution. Accordingly, all subsequent NMR experiments were carried out for 1 (5 mM) in DMSO-d 6 , at 40 1C. To identify and sequence-specifically assign the amino acid residues of 1, NMR spectra, including 1 H, DEPT, gHSQC-DEPT, gHMBC, gDQF-COSY, TOCSY and ROESY were recorded. To identify amino acid residues of 1, analysis of the gDQF-COSY spectrum enabled the assignment of aromatic moieties of Trp by analysis of the 3 J HÀH scalar couplings. For example, the indole N-proton at d H 10.71 was correlated with d H 7.11 (H-2) in the Trp 1 residue. In turn, six amino acid residues of 1 including Glu, Thr, Lys, Ala, 3mGlu and Ile were unambiguously identified after analyses of the TOCSY and gHSQC-DEPT data. In these cases, the TOCSY spectrum reveals the intraresidue 1 H-1 H spin systems extending from each exchangeable backbone amide proton through to the nonexchangeable side-chain protons of each residue. gHSQC-DEPT is a phase-sensitive 2D NMR experiment similar to HSQC (CH and CH 3 in one phase, and CH 2 in the opposite phase). For example, the amino acid residue Thr of 1 was identified as described below. The TOCSY spectrum revealed spin systems for the Thr residue in both the major and minor conformers, with assignments for the minor conformer Hz) . Nevertheless, assignments of the remaining Asp and Asn residues were challenging because of their heavily overlapping H-a and H 2 -b signals attributable to the repeating units containing the same spin system pattern. To resolve this issue, the ROESY spectral data were collected to trace the sequence-specific resonance assignment of 1, especially useful for two Asp and two Asn residues. Summarized as a chart in Figure 4 , most backbone connectivities were confirmed by the inter-residue dipolar correlations (NOE) of amide protons with the side chain and H-a protons of the neighboring residues in the sequence. More importantly, spatial correlations between the Thr 4 NH at d 7.85 and the Asn 3 H-a at d 4.63 and NH at d 8.08 led to the assignment of NMR signals of the Asn 3 residue after carefully deducing the spin system containing the NH at d 8.08 from the TOCSY spectrum. Using a similar approach, NMR signals of Asp 7 , Asp 9 and D-Asn 11 residues were individually assigned based on their backbone NOE correlations between H-a and neighboring amide protons. Furthermore, a series of NOEs (Figure 4 ) observed for 1 should facilitate the calculation of the three-dimensional structure of 1 in the future. Thus, the structure of 1 was deter-
to which the trivial name A54145E(Asn 3 Asp 9 ) has been assigned.
Compound 1 obtained from S. fradiae DA1489 was tested for in vitro antibacterial activity against S. aureus in the presence of pulmonary surfactant using a microdilution technique, following CLSI standards as described, 4 and it exhibited a MIC of 2 mg ml À1 in the presence of 1% of pulmonary surfactant, 18 whereas the daptomycin control showed an MIC of 64 mg ml À1 . The superior antibacterial activity in the presence of bovine surfactant suggests that further investigations of compound 1 in animal models would be warranted. To our knowledge, this is first example characterizing the novel lipopeptide analog by the complete assignment of NMR proton and carbon signals and determination of the D-stereochemistry of three amino acids using an enantiomer-labeling method. The current study supports the predictions made on the basis of the gene deletions in the engineered S. fradiae strain, and points out the predictive power of DNA sequence analysis of NRPS genes to assign the stereochemistry of the individual amino acids by the presence or absence of epimerase domains in individual modules. 9, 16 
EXPERIMENTAL PROCEDURE General experimental procedures
Melting points were determined using a Thomas-Hoover capillary melting point apparatus (Thomas Scientific, Swedesboro, NJ, USA) and are uncorrected. Optical rotations were recorded by a Perkin-Elmer polarimeter 341 (Perkin-Elmer, Waltham, MA, USA). UV spectra were measured on an Evolution 300 UV spectrophotometer (Thermo Corporation, Waltham, MA, USA) and IR spectra on a Thermo Nicolet 380 FT-IR spectrometer. NMR spectra were recorded on a Varian 600 MHz NMR spectrometer (Agilent Technologies, Santa Clara, CA, USA) with standard pulse programs and 1D-and 2D NMR data were processed by MestReNova software (Mestrelab Research, Santiago de Compostela, Spain). HR-ESI-MS data were obtained from a Finnigan LTQ Orbitrap mass spectrometer (Thermo Corporation). Column chromatography was conducted on Diaion HP20 resins (Mitsubishi Chemical, Tokyo, Japan) and Sephadex LH-20 (GE Healthcare Biosciences, Piscataway, NJ, USA). Analytical HPLC was performed at ambient temperature using a Waters Alliance 2690 HPLC system and a 996-photodiode array detector (Waters, Milford, MA, USA). Semi-preparative HPLC was performed on a Varian system equipped with two-model SD-1 PrepStar solvent delivery modules, a PDA ProStar detector, a ProStar injector and a model 701 fraction collector.
Strains, media and fermentation conditions
Media and growth conditions were as described previously. 10, 14, 18 Engineered strain S. fradiae DA1489 was constructed and fermented in DSF production medium supplemented with 0.79% (w/v) of L-Ile as described. 18 S. aureus ATCC 29213 was used for bioassay of lipopeptide antibiotic activity. 8 
HPLC analyses
Target compound 1 was analyzed by a Waters HPLC system with a Waters symmetry C 8 column (4.6Â250 mm, 5 mm) and a Waters guard symmetry C 8 cartridge (4.6Â20 mm, 5 mm). Mobile solvent systems included CH 3 CN plus 0.01% TFA (v/v) modifier (solvent A) and water plus 0.01% TFA (v/v) modifier (solvent B). The mobile phase, flowing at 1.5 ml min À1 , was linearly changed from 30 to 45% A over 14 min, washed at 90% A (2 min) and equilibrated with 30% A (4 min). In HPLC chromatograms, a prominent peak with retention time (t R ) at 8.82 min was identified as the predicted lipopeptide 1 by the A54145-like characteristic UV spectrum (l max 221, 279 and 288 nm) and ESI-MS data at m/z 1626. 8 [M+H] + .
Extraction and isolation
Production culture broth of DA1489 (5 l) was centrifuged to remove biomass, and the supernatant was loaded onto an open glass column packed with preconditioned 500 ml Diaion HP20 resin (60Â500 mm) in water. The column was sequentially eluted with 1.5 l each of water, 10% MeOH, 30% MeOH and MeOH. The MeOH eluate was concentrated by rotary evaporation and lyophilized to give 2 g crude material, which was further subjected to a 500 ml Sephadex LH-20 column chromatography eluting with a mixture of MeOH-H 2 O (1:1). Fractions containing target component were collected, giving 720 mg of lyophilized powder. Further purification was achieved by semipreparative HPLC using a Waters SymmetryPrep C 8 column (19Â300 mm, 7 mm) at a flow rate of 20 ml min À1 with a linear gradient from 33 to 40% A over 20 min, washing the column with 90% A for 4 min and equilibrating with 33% A for 6 min. HPLC traces were recorded at UV 220 nm. Compound 1 (16 mg) was obtained at t R 17.6 min. Alkali hydrolysis of 1. A 1 ml aliquot of 1 (10 mg ml À1 ) was prepared in a 1.5 ml vial, to which 1 mg lithium hydroxide monohydrate was added. After 20 min at room temperature, the hydrolysis reaction was quenched by adding 10 ml of formic acid, and the hydrolysate 1a was subjected to LC-MS-MS analysis.
A54145E(Asn
LC-MS-MS analysis of 1a. LC-MS-MS analysis was carried out using a Finnigan Surveyor HPLC system interfaced to a Finnigan LTQ Orbitrap mass spectrometer. A Waters Sunfire C 8 column (2.1Â100 mm, 3.5 mm) was used for HPLC separations. The sample injection volume was 10 ml. The solvent systems were water containing 0.1% formic acid (solvent C) and CH 3 CN containing 0.1% formic acid (solvent D). The linear gradient for separation was set up as from 10 to 90% D over 10 min, and then the column was cleaned with 90% D for 2 min and equilibrated with 10% D for 3 min. The flow rate was 350 ml min À1 . Positive ESI source conditions were sheath gas flow rate at 30 (in arbitrary units), auxiliary gas flow rate at 2 (in arbitrary units), ion spray voltage at 2 kV, capillary temperature at 350 1C, capillary voltage at 40 V and tube lens voltage at 250 V. Normalized collision energy was 60%.
MS-MS data used for amino acid sequence analysis of 1 were acquired from its hydrolysate 1a, which was confirmed by the [M+H] + m/z at 1644.8 along with its characteristic UV spectra at l max 221, 279 and 288 nm.
Analyses of amino acids optical purity
A modified enantiomer-labeling method was employed to quantitatively determine the enantiomeric purity of amino acids according to previously established protocols. 23 In brief, compound 1 (100 nmol) was hydrolyzed in 0. Figure 4 Inter-residue NOEs observed in the ROESY data set of 1 at a mixing time of 100 ms. H N i stands for the amide bond proton of a certain amino acid residue within the molecule. H a i and H b i stand for protons at positions a and b in an amino acid residue.
for 10 min. After the excess of reagents were removed by a stream of nitrogen, the residue was dissolved in 0.15 ml of toluene and injected into the GC. All of the GC-MS analyses were performed using a Varian Saturn 2000/HP5973 GC-MS system (Agilent Technologies, Santa Clara, CA, USA), including a Saturn 2000 software/HP Chem integrator. The GC was fitted with a deactivated glass capillary column (20 000Â0.31 mm) coated with Chirasil-Val (film thickness 0.2 mm) (Applied Sciences Laboratories, State College, PA, USA). Hydrogen was used as the carrier gas at a flow rate of 1.5 ml min À1 . Sample introduction (0.5 ml) was made in split mode with a 25:1 split ratio and an injector temperature of 190 1C. The temperature of the column oven was programmed at 65 1C for 3 min, followed by a linear gradient of 65-190 1C over 31 min.
Determination of N-acyl substituent
A panel of nine authentic fatty acid-Trp (FA-Trp) amides was prepared as described previously. 21 All chemicals used for coupling reactions were obtained in analytical grade. Decanoic-(nC 10 ), lauric-(nC 12 ), tridecanoic-(nC 13 ) acids, Ltryptophan (Trp), 1-hydroxy-benzotriazole hydrate (HOBt) and O-(7-azabenzotriazol-1-yl)-N,N,N¢,N¢-tetramethyl-uronium PF6 (HATU) were purchased from Sigma-Aldrich (St Louis, MO, USA). The compounds 8-methylnonanoic The N-acyl substituent of 1 was determined by acidic hydrolysis of 1 to produce the corresponding FA tail, followed by coupling with Trp to further produce the resultant tryptophanyl amide. The HPLC retention times (t R ) and UV spectra were compared with those of authentic FA-Trp amides. Compound 1 (3 mg) was dissolved with 10 N HCl (1 ml) in a 1 ml vacuum hydrolysis tube. The tube was evacuated and then placed in a 110 1C heating block for 16 h. After cooling, CH 2 Cl 2 (1 ml Â three times) was added to extract the resultant FA. After the CH 2 Cl 2 extract was dried under a stream of N 2 , 10 mM Trp, 10 mM HOBt, 10 mM HATU, 0.75 ml DMF and 10 ml DIPEA were added sequentially. After 2 h incubation at room temperature with shaking at 200 r.p.m., a 10 ml aliquot of the reaction mixture was analyzed by analytical HPLC as described above to acquire the t R and UV spectrum. To confirm the presence of the N-acyl group, a panel of authentic FA-Trp amides was further spiked into the lipopeptide reaction mixture for HPLC analysis.
